U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.635_637del (p.Ser212del) AND not provided

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Nov 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000482920.5

Allele description [Variation Report for NM_000162.5(GCK):c.635_637del (p.Ser212del)]

NM_000162.5(GCK):c.635_637del (p.Ser212del)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.635_637del (p.Ser212del)
HGVS:
  • NC_000007.14:g.44149804_44149806del
  • NG_008847.2:g.53367_53369del
  • NM_000162.3:c.635_637del
  • NM_000162.5:c.635_637delMANE SELECT
  • NM_001354800.1:c.635_637del
  • NM_033507.3:c.638_640del
  • NM_033508.3:c.632_634del
  • NP_000153.1:p.Ser212del
  • NP_001341729.1:p.Ser212del
  • NP_277042.1:p.Ser213del
  • NP_277043.1:p.Ser211del
  • LRG_1074t1:c.635_637del
  • LRG_1074t2:c.638_640del
  • LRG_1074:g.53367_53369del
  • LRG_1074p1:p.Ser212del
  • LRG_1074p2:p.Ser213del
  • NC_000007.13:g.44189403_44189405del
  • NM_000162.3:c.635_637delCCT
Protein change:
S211del
Links:
dbSNP: rs193922314
NCBI 1000 Genomes Browser:
rs193922314
Molecular consequence:
  • NM_000162.5:c.635_637del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001354800.1:c.635_637del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_033507.3:c.638_640del - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_033508.3:c.632_634del - inframe_deletion - [Sequence Ontology: SO:0001822]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000568574GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely pathogenic
(Nov 13, 2023)
germlineclinical testing

Citation Link,

SCV003839555Genetic Services Laboratory, University of Chicago
no assertion criteria provided
Likely pathogenic
(Aug 31, 2022)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000568574.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

In-frame deletion of 1 amino acid in a non-repeat region predicted to critically alter the protein; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Identified in patients with MODY in published literature and referred for genetic testing at GeneDx in association with MODY (PMID: 29927023, 24804978); This variant is associated with the following publications: (PMID: 19790256, 27167055, 24804978, 29927023)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV003839555.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

DNA sequence analysis of the GCK gene demonstrated a three base pair deletion in exon 6, c.635_637del. This in-frame deletion is predicted to result in the deletion of an amino acid residue, p.Ser212del. This deletion has been previously described in individuals with GCK -related MODY and neonatal hyperglycemia (PMIDs: 24804978, 29927023, 27167055 and 34374989). This sequence change has been described in the gnomAD database with a global population frequency of 0.0004% (dbSNP rs193922314). These collective evidences indicate that this sequence change is likely pathogenic, however functional studies have not been performed to prove this conclusively.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024